Loading market quotes…

Subscribe free
Wall Street Radar4 minFreeGBC Research

TIL (Instil Bio): stock research | Radar 6

Volume 6: Slashed Rates, Soaring Stocks: What's Next?

📈 Momentum Metrics: Leveraging data-driven insights to pinpoint stocks with upward potential. 📊


🎢 High-Volatility Thrill Rides 🎢

TIL (Instil Bio)

What they do:: Instil Bio is a clinical-stage biopharmaceutical company focused on developing novel cancer immunotherapies.

Why watch? 🚀💉 TIL skyrocketed higher on 9 Sept for this news: At the beginning of 2024, Instil Bio was still trying to develop cell-based cancer therapies that rely on tumor-infiltrating lymphocytes, or TILs. In August, the company switched gears and in-licensed IMM2510, a bispecific antibody that targets programmed death ligand 1 (PD-L1) and vascular endothelial growth factor (VEGF).

TIL (Instil Bio): stock research | Radar 6 · figure 1

VOXX (VOXX International Corporation)

What they do: Consumer electronics

Why watch? Symmetrical triangle ready to break with low volume consolidation. Recent news about maximizing shareholder value and exploring strategic alternatives could be the spark this stock needs. Get ready for a potential sound investment! 🎧💼

TIL (Instil Bio): stock research | Radar 6 · figure 2

QH (Quhuo Limited)

What they do: Quhuo Ltd. engages in the development of a workforce operational solution platform.

Why watch? 📰💼 Fluff news this week to keep the stock listed on the Nasdaq (minimum requirement 1$) 10ema is catching up, we need to understand if a second leg higher will come after a little bit of digestion, or if it will slowly come back to 50 cents. volume is the highest from the IPO.

TIL (Instil Bio): stock research | Radar 6 · figure 3

TEM (Tempus AI Inc)

What they do: Healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare.

Why watch? 🏋️‍♂️🎯 Already broke the channel (suggested in last week's watchlist) but the stock is digesting the move near the 55-56 level where a seller is present. clearing the level should send the stock higher if the markets agree

TIL (Instil Bio): stock research | Radar 6 · figure 4

FBLG (FibroBiologics Inc)

What they do: FibroBiologics, Inc. engages in the development and commercialization of cell therapies.

Why watch? 🏆📈 Is making a beautiful cup with a handle on the daily chart, recent IPO, last week was the highest volume since the IPO, 10 and 20 ema watched up giving support. breaking the 3.60 mark should send the stock for the next leg higher. great symmetrical triangle.

TIL (Instil Bio): stock research | Radar 6 · figure 5

UMAC (Unusual Machines Inc)

What they do: Unusual Machines, Inc. is a development-stage technology company, which engages in the provision of drone solutions with a focus on first-person view (FPV) technology.

Why watch? 🔍💬 This is a recent IPO, a lot of chatter on social media about this company, also really interesting for a medium-term hold. The volume is low so pay attention and leave more room than usual. 1.40 strong support, 1.70 strong resistance. we need real volume coming in.

TIL (Instil Bio): stock research | Radar 6 · figure 6

🏄‍♂️ Medium-Risk Wave Riders 🏄‍♂️

RDFN (Redfin)

What they do: Redfin is a technology-powered real estate brokerage, combining its full-service agents with modern technology to redefine real estate in the consumer's favor.

Why watch? 🏠💪 Falling wedge forming, a really strong stock in one of the sectors that will benefit the most from rate cuts? a new leader is shaping up?

TIL (Instil Bio): stock research | Radar 6 · 🏄‍♂️ Medium-Risk Wave Riders 🏄‍♂️ · figure 7

ZK (ZEEKR Intelligent Technology Holding Ltd. ADR)

What they do: Chinese electric vehicle manufacturer

Why watch? Recent IPO breaking out of a descending channel and now forming a pennant, with potential for new highs.

TIL (Instil Bio): stock research | Radar 6 · 🏄‍♂️ Medium-Risk Wave Riders 🏄‍♂️ · figure 8

ANNX (Annexon)

What they do: Annexon is a clinical-stage biopharmaceutical company developing a new class of complementary medicines for patients with classical complement-mediated disorders of the body, brain, and eye.

Why watch? 🚩🏁 A recent IPO, broke last week a key level on the weekly and not is creating a little flag over that level.

TIL (Instil Bio): stock research | Radar 6 · 🏄‍♂️ Medium-Risk Wave Riders 🏄‍♂️ · figure 9

CLPT (ClearPoint Neuro)

What they do: ClearPoint Neuro is a medical device company that develops and commercializes innovative platforms for performing minimally invasive surgical procedures in the brain.

Why watch? 🧠💹 In the middle of August the stock broke with volume the 11 level on the weekly and now is forming a pennant digesting the big move, almost 100% in 25 days!

TIL (Instil Bio): stock research | Radar 6 · 🏄‍♂️ Medium-Risk Wave Riders 🏄‍♂️ · figure 10

AMSC (American Superconductor)

What they do: American Superconductor Corporation provides megawatt-scale solutions that lower the cost of wind power and enhance the performance of the power grid.

Why watch? 🌪️🔋 The stock made an incredible run in April when the semiconductor sector was hot with NVDA. Now the stock is forming a pennant with 10,20 and 50 moving averages supporting the stock on the consolidation.

TIL (Instil Bio): stock research | Radar 6 · 🏄‍♂️ Medium-Risk Wave Riders 🏄‍♂️ · figure 11

DCTH (Delcath Systems)

What they do: Delcath Systems is an interventional oncology company focused on the treatment of primary and metastatic liver cancers.

Why watch? 🏥📊 Made a powerful 50% in 4 days at the end of August, now is retesting the previous resistance, acting as support. The falling wedge if the level will hold can make the start for a second move.

TIL (Instil Bio): stock research | Radar 6 · 🏄‍♂️ Medium-Risk Wave Riders 🏄‍♂️ · figure 12

🛡️ Low-Risk Safe Harbors 🛡️

RBLX (Roblox)

What they do: Roblox is an online entertainment platform that allows users to play, create, and monetize games.

Why watch? 🎮🔑 The stock has troubles to break the 47 level since 2022, it's almost two years. when the stock breaks the level with volume the move can be very very powerful.

TIL (Instil Bio): stock research | Radar 6 · 🛡️ Low-Risk Safe Harbors 🛡️ · figure 13

VRNA (Verona Pharma)

What they do: Verona Pharma is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases.

Why watch? 💨🚀 Broke the 29 level and now was tested a couple of times as support. the break of 30 level can be important, the stock is at all-time highs so no new resistance is to be cleared from now on.

TIL (Instil Bio): stock research | Radar 6 · 🛡️ Low-Risk Safe Harbors 🛡️ · figure 14

BMY (Bristol Myers Squibb)

What they do: Bristol Myers Squibb is a global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for patients with serious diseases.

Why watch? 💊📉 The stock is creating a beautiful VCP pattern and volume is drying up. the downtrendline is from March and is what is holding the stock to move higher. Clearing the 50 level is key.

TIL (Instil Bio): stock research | Radar 6 · 🛡️ Low-Risk Safe Harbors 🛡️ · figure 15

May your stop losses be respected, your take profits hit, and your trading psychology remains unshakeable! 🛑💪

Newsletter

This piece was free. The next one lands on Sunday.

Every Sunday, we analyze up to ten stocks and publish our market view. A subscription includes the full research, price levels and our live positions in the chat. The free section arrives by email.

Related research
CSLR (Complete Solaria): stock research | Radar 8Wall Street Radar · 29.09.2024BOF (BranchOut Food): stock research | Radar 5Wall Street Radar · 15.09.2024Enphase (ENPH) and the shift from tech to defensive stocks | Radar 73Wall Street Radar · 08.02.20262026 investment themes: space, AI and infrastructure | X-Ray 29Equity X-Ray · 31.12.2025Baidu (BIDU), tariffs and trade-war risk | Radar 70Wall Street Radar · 18.01.2026 Full archive →
FREE · EVERY SUNDAY

Get the next Radar
before Monday’s open.

The first name, the reasoning, and our public research.

FREE · EVERY SUNDAYGet the watchlist